Literature DB >> 20829419

Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis.

Elias Xirouchakis1, Laura Marelli, Evangelos Cholongitas, Pinelopi Manousou, Vincenza Calvaruso, Maria Pleguezuelo, Gian Piero Guerrini, Sergio Maimone, Andrew Kerry, Mark Hajjawi, Devaki Nair, Michael Thomas, David Patch, Andrew Kenneth Burroughs.   

Abstract

BACKGROUND AND OBJECTIVES: Renal function is an important predictor of survival in cirrhosis and liver transplantation. GFR estimates using serum cystatin C (CysC) are proposed as better predictors of renal function than ones on the basis of serum creatinine (Cr). Our aims were: (1) evaluate correlations between serum CysC and different methods of creatinine measurements; (2) compare CysC and Cr GFR formulas with (51)Cr-EDTA; and (3) evaluate liver-related parameters potentially influencing GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: 254 blood samples in 65 patients with cirrhosis correlating CysC with four Cr methods were used; another 74 patients comparing (51)Cr-EDTA GFR to Modification of Diet in Renal Disease and Larsson and Hoek formulas for CysC were also included. Agreement was assessed using Bland-Altman plots and concordance correlation coefficients. Multivariate linear regression analysis was used for GFR predictors.
RESULTS: Serum CysC correlated modestly with O'Leary modified Jaffe, compensated kinetic Jaffe, enzymatic creatinine, and standard kinetic Jaffe 0.72/0.71/0.72/0.72 (all P < 0.001). Bland-Altman agreement with (51)Cr-EDTA GFR was poor; the best agreement was Modification of Diet in Renal Disease (concordance 0.61; 95% CI, 0.47 to 0.71); the worst agreement was the Hoek formula (concordance 0.46; 95% CI, 0.27 to 0.61). A new GFR formula including the Child-Pugh score improved the accuracy of Cr GFR formulas compared with (51)Cr-EDTA GFR.
CONCLUSIONS: Estimated GFR in cirrhosis is not better with CysC formulas compared with creatinine ones: specific formulas may be necessary.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829419      PMCID: PMC3022253          DOI: 10.2215/CJN.03400410

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  37 in total

1.  A note on concordance correlation coefficient.

Authors:  J J Liao; J W Lewis
Journal:  PDA J Pharm Sci Technol       Date:  2000 Jan-Feb

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis.

Authors:  Rocco Orlando; Michele Mussap; Mario Plebani; Pierpaolo Piccoli; Sara De Martin; Maura Floreani; Roberto Padrini; Pietro Palatini
Journal:  Clin Chem       Date:  2002-06       Impact factor: 8.327

4.  Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations.

Authors:  Thomas A Gonwa; Linda Jennings; Martin L Mai; Paul C Stark; Andrew S Levey; Goran B Klintmalm
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

5.  Elevation of serum cystatin C concentrations in patients with chronic liver disease.

Authors:  M Takeuchi; Y Fukuda; I Nakano; Y Katano; T Hayakawa
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 2.566

Review 6.  Cystatin C.

Authors:  David J Newman
Journal:  Ann Clin Biochem       Date:  2002-03       Impact factor: 2.057

7.  Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.

Authors:  A Cárdenas; P Ginès; J Uriz; X Bessa; J M Salmerón; A Mas; R Ortega; B Calahorra; D De Las Heras; J Bosch; V Arroyo; J Rodés
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

8.  Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver.

Authors:  A L Gerbes; V Gülberg; M Bilzer; M Vogeser
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

9.  A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.

Authors:  Frans J Hoek; Frits A W Kemperman; Raymond T Krediet
Journal:  Nephrol Dial Transplant       Date:  2003-10       Impact factor: 5.992

10.  Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK.

Authors:  Carol Goulding; Evangelous Cholongitas; Devi Nair; Andrew Kerry; David Patch; Murat Akyol; Simon Walker; Derek Manas; David Mc Clure; Liesl Smith; Neville Jamieson; Ingela Oberg; David Cartwright; Andrew K Burroughs
Journal:  Nephrol Dial Transplant       Date:  2009-11-05       Impact factor: 5.992

View more
  21 in total

Review 1.  GFR Estimating Equations and Liver Disease.

Authors:  Tomasz Beben; Dena E Rifkin
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

Review 2.  The applicability of eGFR equations to different populations.

Authors:  Pierre Delanaye; Christophe Mariat
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

Review 3.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

4.  Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites.

Authors:  Carl Adam Wesolowski; Lin Ling; Elias Xirouchakis; Maria T Burniston; Richard C Puetter; Paul S Babyn; Ioannis G Giamalis; Andrew K Burroughs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-01       Impact factor: 9.236

Review 5.  Difficulties in diagnosing acute kidney injury post liver transplantation using serum creatinine based diagnostic criteria.

Authors:  Banwari Agarwal; Andrew Davenport
Journal:  World J Hepatol       Date:  2014-10-27

Review 6.  Management of patients with hepatitis B in special populations.

Authors:  Evangelos Cholongitas; Konstantinos Tziomalos; Chrysoula Pipili
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

7.  Difficulties in assessing renal function in patients with cirrhosis: potential impact on patient treatment.

Authors:  Andrew Davenport
Journal:  Intensive Care Med       Date:  2011-03-04       Impact factor: 17.440

Review 8.  Renal dysfunction in patients with cirrhosis: Where do we stand?

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

9.  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.

Authors:  Evangelos Cholongitas; Ioannis Goulis; Maria Ioannidou; Stergios Soulaidopoulos; Parthenis Chalevas; Evangelos Akriviadis
Journal:  Hepatol Int       Date:  2016-08-30       Impact factor: 6.047

10.  Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis.

Authors:  Dorđe Ćulafić; Miloš Štulić; Radmila Obrenović; Danijela Miletić; Dragana Mijač; Milica Stojković; Marija Jovanović; Milica Ćulafić
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.